MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

09 Feb 2024 Evaluate
The December 2023 quarter revenue stood at Rs. 23713.00 millions, up 17.80% as compared to Rs. 20130.00 millions during the corresponding quarter last year.The Profit  for the quarter ended December 2023 of  Rs. 4504.00  millions  grew by 76.01% from Rs. 2559.00 millions.OP of the company witnessed a marginal growth to 8059.00 millions from 5949.00 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 23713.00 20130.00 17.80 74863.00 61523.00 21.68 87316.00 78369.00 11.42
Other Income 1236.00 2102.00 -41.20 8272.00 6115.00 35.27 5484.00 1787.00 206.88
PBIDT 8059.00 5949.00 35.47 32132.00 19791.00 62.36 30028.00 20968.00 43.21
Interest 1039.00 885.00 17.40 2845.00 1932.00 47.26 2782.00 1349.00 106.23
PBDT 7020.00 5064.00 38.63 29287.00 17859.00 63.99 25208.00 16426.00 53.46
Depreciation 1277.00 1216.00 5.02 3738.00 3687.00 1.38 4886.00 4787.00 2.07
PBT 5743.00 3848.00 49.25 25549.00 14172.00 80.28 20322.00 11639.00 74.60
TAX 1239.00 1289.00 -3.88 5186.00 3787.00 36.94 5030.00 3060.00 64.38
Deferred Tax 51.00 427.00 -88.06 -82.00 465.00 -117.63 412.00 458.00 -10.04
PAT 4504.00 2559.00 76.01 20363.00 10385.00 96.08 15292.00 8579.00 78.25
Equity 1012.00 1012.00 0.00 1012.00 1024.00 -1.17 1012.00 1024.00 -1.17
PBIDTM(%) 33.99 29.55 15.00 42.92 32.17 33.43 34.39 26.76 28.53
Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..